Oxygen Defect Engineering in ZnO Single Crystals

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The concentration and spatial distribution of point defects, particularly oxygen vacancies, in zinc oxide (ZnO) hinder its performance in optoelectronic and photonic applications, as they act as recombination centers and hinder p-type doping, necessitating effective methods for control.

Innovation Solution

Engineering a defect concentration in metal oxide single crystals by exposing them to molecular oxygen at elevated temperatures, injecting atomic oxygen as interstitials to annihilate vacancies, achieving high diffusivity and concentrations of interstitial oxygen, thereby stabilizing polar surfaces and enhancing material performance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If ZnO is grown or treated under conventional conditions, then oxygen vacancies are introduced into the crystal, but these vacancies act as recombination centers that lower UV band edge emissions and photocatalytic efficiencies

Engineering Contradiction:
Improvephotocatalytic efficiencyVSAvoidoxygen vacancy concentration
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary action by pre-treating the ZnO crystal with oxygen plasma or oxygen atmosphere before the main growth process, or by introducing oxygen during specific growth stages. This preliminary oxygen treatment reduces the formation of oxygen vacancies during subsequent crystal growth, thereby maintaining high photocatalytic efficiency without requiring post-growth correction

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent converts the harmful effect of oxygen vacancies into a beneficial process by intentionally creating controlled oxygen deficiency during growth, then subsequently annealing the crystal in oxygen atmosphere. The controlled creation and removal of vacancies demonstrates understanding of the defect dynamics, transforming what was previously an unavoidable harm into a controllable process that enhances crystal quality

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Adaptability or versatility

If oxygen vacancies are present in ZnO, then charge compensation occurs, but this hinders p-type doping in natively n-type oxides

Engineering Contradiction:
Improvedoping capabilityVSAvoidcharge compensation
Core Design Contradiction:
Adaptability or versatilityVSObject-generated harmful factors

Solution Approach 1:

The patent applies preliminary action by pre-annealing ZnO crystals in oxygen atmosphere or treating them with oxygen plasma before doping experiments. This preliminary oxygen treatment reduces the concentration of oxygen vacancies and associated charge compensation effects, creating a more favorable starting condition for successful p-type doping that would otherwise be hindered by native n-type characteristics

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent employs parameter changes by systematically varying oxygen partial pressure, temperature, and atmosphere composition during crystal growth and post-growth treatment. By adjusting these parameters, the patent optimizes the balance between maintaining n-type conductivity for certain applications and reducing charge compensation to enable p-type doping in other applications, demonstrating versatile control over electrical properties

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If atomic oxygen is injected into the single crystal at high diffusion rates, then interstitial oxygen concentration increases, but this requires precise control of diffusion parameters

Engineering Contradiction:
Improvedefect concentration controlVSAvoiddiffusion control system
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent replaces complex mechanical diffusion control systems with a chemically driven approach using oxygen plasma or reactive gas atmospheres. Instead of mechanically controlling atomic oxygen flux through complex equipment, the patent uses chemical reactions (plasma generation, gas-phase oxidation) to produce and deliver atomic oxygen, significantly simplifying the control system while achieving precise defect concentration control

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces oxygen plasma or oxygen-containing gas atmosphere as an intermediary medium between the external environment and the crystal lattice. This intermediary carries atomic oxygen to the crystal surface and facilitates controlled incorporation into interstitial sites, mediating the complex diffusion process and enabling precise control of interstitial oxygen concentration without direct mechanical intervention

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach results in substantial increases in oxygen diffusivity and interstitial concentrations, improving the material's performance by reducing oxygen vacancies, enhancing photoluminescence, and increasing the efficiency of ZnO in optoelectronic devices.

Implementation Method 1

The adsorption and ensuing dissociation of O2 onto polar metal oxide surfaces, followed by the injection of surface O adatoms into the interior of the metal oxide crystal

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

The adsorption and ensuing dissociation of O2 onto polar metal oxide surfaces

Methodology Applied
Scientific EffectDissociation: Photodissociation

Implementation Method 3

injecting atomic oxygen into the single crystal at an effective diffusion rate Deff of at least about 10−16 cm2/s

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 4

exposing a metal oxide single crystal having a polar surface to molecular oxygen at a temperature of about 850° C. or less

Methodology Applied
Scientific EffectThermal activation: Heating

Data Source

PatentUS10161062B2Composition comprising an engineered defect concentration
Publication Date: 2018.12.25 THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS
  • US10161062B2 patent drawing
  • US10161062B2 patent drawing
  • US10161062B2 patent drawing

AI summary

A composition comprising an engineered defect concentration comprises a metal oxide single crystal having a polar surface and a bulk concentration of interstitial oxygen (Oi) of at least about 1014 atoms/cm3. The polar surface comprises a concentration of impurity species of about 5% or less of a monolayer. A method of engineering a defect concentration in a single crystal comprises exposing a metal oxide single crystal having a polar surface to molecular oxygen at a temperature of about 850° C. or less, and injecting atomic oxygen into the single crystal at an effective diffusion rate Deff of at least about 10−16 cm2/s.